tazarotene has been researched along with Carcinoma in Situ in 1 studies
tazarotene: a topical acetylenic retinoid; a topical kerytolytic
tazarotene : The ethyl ester of tazarotenic acid. A prodrug for tazarotenic acid, it is used for the treatment of psoriasis, acne, and sun-damaged skin.
Carcinoma in Situ: A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bardazzi, F | 1 |
| Bianchi, F | 1 |
| Parente, G | 1 |
| Guareschi, E | 1 |
| Landi, C | 1 |
1 other study available for tazarotene and Carcinoma in Situ
| Article | Year |
|---|---|
A pilot study on the use of topical tazarotene to treat squamous cell carcinoma in situ.
Topics: Administration, Topical; Aged; Aged, 80 and over; Carcinoma in Situ; Carcinoma, Squamous Cell; Derma | 2005 |